Gapping down
In reaction to earnings/guidance:
- CHTR -4.1%, EGHT -3.7%, BZH -3%, AX -2.7%, PLL -2.7% (quarterly update), RDY -2.4%, MDLZ -2.3%, BAH -1.5%, CVX -1.4%, PSX -1.3%, HON -0.9%, SAP -0.7%
Other news:
- OTLK -22.6% (prices offering of 35 mln shares of common stock at $1.00 per share)
- DS -16.9% (prices offering of 20,833,334 shares of common stock at $2.40 per share for gross proceeds of ~$50 million)
- ADMP -12.9% (stock offering)
- EVLO -8.6% (prices offering of 4.5 mln shares of common stock at 15.00 per share)
- STIM -6.7% (prices offering of 4.84 mln shares of common stock at $15.50 per share)
- EGLE -5.7% (SALT to sell to sell SBI Virgo to EGLE)
- DNMR -4.7% (stock offering)
- SALT -4.2% (SALT to sell to sell SBI Virgo to EGLE)
- DX -2.9% (prices 2.75 mln shares of common stock for gross proceeds of approximately $49.1 mln)
- DLX -2.9% (announces new agreement with Truist)
- DCT -2.3% (prices offering of 9 mln shares of common stock at $46.00 per share)
- TALO -1.8% (comments on recent regulatory actions)
- VRTX -1% (FDA clears IND, enabling co to proceed with initiating a clinical trial for VX-880)
Analyst comments:
- AKBA -2.5% (downgraded to Underweight from Neutral at JP Morgan)
- BEAM -2% (downgraded to Neutral from Overweight at JP Morgan)
- JAZZ -2% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- RGA -1.9% (downgraded to Underperform from Neutral at Credit Suisse)
- CALX -1.7% (downgraded to Market Perform from Outperform at Northland Capital)
- LNC -1.5% (downgraded to Underperform from Outperform at Credit Suisse)
- AUTL -1.2% (downgraded to Neutral from Overweight at JP Morgan)
- DXC -1% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- GKOS -0.9% (downgraded to Neutral from Overweight at Piper Sandler)
- BAX -0.8% (downgraded to Neutral from Overweight at Piper Sandler)